SLC6A3

Chr 5AR

solute carrier family 6 member 3

Mediates sodium- and chloride-dependent transport of dopamine (PubMed:10375632, PubMed:11093780, PubMed:1406597, PubMed:15505207, PubMed:19478460, PubMed:39112701, PubMed:39112703, PubMed:39112705, PubMed:8302271). Also mediates sodium- and chloride-dependent transport of norepinephrine (also known as noradrenaline) (By similarity). Regulator of light-dependent retinal hyaloid vessel regression, downstream of OPN5 signaling (By similarity)

Primary Disease Associations & Inheritance

{Nicotine dependence, protection against}MIM #188890
Parkinsonism-dystonia, infantile, 1MIM #613135
AR
716
ClinVar variants
44
Pathogenic / LP
1.00
pLI score· haploinsufficient
4
Active trials
Clinical SummarySLC6A3
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
44 Pathogenic / Likely Pathogenic· 147 VUS of 716 total submissions
💊
Clinical Trials
4 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.25LOEUF
pLI 0.998
Z-score 4.65
OE 0.10 (0.040.25)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
2.29Z-score
OE missense 0.67 (0.600.74)
249 obs / 373.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.10 (0.040.25)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.67 (0.600.74)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.19
01.21.6
LoF obs/exp: 3 / 30.9Missense obs/exp: 249 / 373.7Syn Z: -1.92

ClinVar Variant Classifications

716 submitted variants in ClinVar

Classification Summary

Pathogenic40
Likely Pathogenic4
VUS147
Likely Benign238
Benign65
Conflicting1
40
Pathogenic
4
Likely Pathogenic
147
VUS
238
Likely Benign
65
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
39
0
40
Likely Pathogenic
3
1
0
0
4
VUS
1
124
21
1
147
Likely Benign
0
4
124
110
238
Benign
0
0
64
1
65
Conflicting
1
Total5129248112495

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC6A3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

SLC6A3-related parkinsonism-dystonia, infantile

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. Disorders
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

{Nicotine dependence, protection against}

MIM #188890

Molecular basis of disorder known

Parkinsonism-dystonia, infantile, 1

MIM #613135

Molecular basis of disorder known

Autosomal recessive
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Imaging genetics in neurodevelopmental psychopathology.
Klein M et al.·Am J Med Genet B Neuropsychiatr Genet
2017Review
Pharmacogenomics of buprenorphine - a narrative review.
Aravindan L et al.·Pharmacogenomics
2025Review
Top 10 resultsSearch PubMed ↗